Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11053219 Substituted pyridines as TYK2 inhibitors

Patent 11053219 was granted and assigned to Esker Therapeutics on July, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 23 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 23 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12122785 Substituted pyridines, pyridazines, pyrimidines, and 1,2,4-triazines as TYK2 inhibitors
0
Edits on 2 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 2 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12103937 Substituted pyridines and pyridazines as TYK2 inhibitors
0
Edits on 11 Sep, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 11 Sep, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12084458 Substituted pyridines, pyridazines, and pyrimidines as TYK2 inhibitors
0
Edits on 13 Jun, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 13 Jun, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12006306 Substituted pyridazines as TYK2 inhibitors
0
Edits on 12 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 12 Dec, 2023
Edits made to:
Article (+347 characters)
Article

Patent abstract

Described herein are pyridine compounds of Formula (XIII) that are useful in treating a TYK2-mediated disorder. In some embodiments, the TYK2-mediated disorder is an autoimmune disorder, an inflammatory disorder, a proliferative disorder, an endocrine disorder, a neurological disorder, or a disorder associated with transplantation

Edits on 10 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 10 Oct, 2023
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Bohan Jin0
Gene Hung0
Qing Dong0
Stephen W. Kaldor0
Edits on 25 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 25 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=11053219
Edits on 6 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 6 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=11053219
Edits on 12 Feb, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 12 Feb, 2022
Edits made to:
Infobox (+8 properties)
‌

 US Patent 11053219 Substituted pyridines as TYK2 inhibitors

Infobox
Is a
Patent
Patent
Current assignee
‌
Esker Therapeutics
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
11053219
Date of patent
July 6, 2021
Patent application number
16938183
Date Filed
July 24, 2020
Patent primary examiner
‌
Douglas M Willis

Find more entities like US Patent 11053219 Substituted pyridines as TYK2 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo